Plasma Concentrations and Bioavailability of Clofibrate After Administration to Human Subjects
- 1 July 1974
- journal article
- research article
- Published by Wiley in The Journal of Clinical Pharmacology
- Vol. 14 (7) , 382-386
- https://doi.org/10.1002/j.1552-4604.1974.tb01415.x
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Variation in Biologic Availability of Digoxin from Four PreparationsNew England Journal of Medicine, 1971
- A study of the availability of six commercial formulations of isoniazidClinical Pharmacology & Therapeutics, 1969
- Long-Term Effects of Clofibrate (Atromid-S) on Serum Lipids in ManCirculation, 1969
- The Efficacy of Clofibrate (CPIB) in Familial HyperlipoproteinemiasPublished by Springer Nature ,1969
- A Primary Prevention Trial Using Clofibrate (Atromid-S)Published by Springer Nature ,1969
- The Effect of Chlorophenoxyisobutyrate (CPIB) in Various Types of Primary HyperlipidemiaPublished by Springer Nature ,1969
- Method of Estimating Relative Absorption of a Drug in a Series of Clinical Studies in Which Blood Levels are Measured After Single and/or Multiple DosesJournal of Pharmaceutical Sciences, 1967
- Reduction of serum triglycerides and cholesterol by ethyl p-chlorophenoxyisobutyrate (CPIB)The American Journal of Cardiology, 1965
- EXPERIMENTAL EVALUATION OF AN ORALLY ACTIVE COMBINATION OF ANDROSTERONE WITH ETHYL CHLOROPHENOXYISOBUTYRATEThe Lancet, 1962
- Modification of Metabolism and Distribution of Lipids by Ethyl ChlorophenoxyisobutyrateNature, 1962